Apyx Medical
APYX
62 hedge funds and large institutions have $58.7M invested in Apyx Medical in 2023 Q3 according to their latest regulatory filings, with 18 funds opening new positions, 18 increasing their positions, 10 reducing their positions, and 11 closing their positions.
1,588% more call options, than puts
Call options by funds: $135K | Put options by funds: $8K
80% more repeat investments, than reductions
Existing positions increased: 18 | Existing positions reduced: 10
64% more first-time investments, than exits
New positions opened: 18 | Existing positions closed: 11
11% more funds holding
Funds holding: 56 → 62 (+6)
1.34% less ownership
Funds ownership: 54.26% → 52.91% (-1.3%)
38% less capital invested
Capital invested by funds: $94.4M → $58.7M (-$35.8M)
67% less funds holding in top 10
Funds holding in top 10: 3 → 1 (-2)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
ACM
AIGH Capital Management
Baltimore,
Maryland
|
+$2.93M |
| 2 |
RA
Royce & Associates
New York
|
+$1.89M |
| 3 |
EIM
Essex Investment Management
Boston,
Massachusetts
|
+$1.73M |
| 4 |
Millennium Management
New York
|
+$1.21M |
| 5 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$950K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
DSCM
Divisadero Street Capital Management
Miami,
Florida
|
-$10.6M |
| 2 |
EI
EAM Investors
Solana Beach,
California
|
-$1.27M |
| 3 |
PVI
Pura Vida Investments
New York
|
-$706K |
| 4 |
GCP
GSA Capital Partners
London,
United Kingdom
|
-$209K |
| 5 |
BFM
Boothbay Fund Management
New York
|
-$201K |
APYX Hedge Fund Activity: Q3 2023 in Review
62 of the 6,310 institutional investors tracked by Wall St. Rank reported a position in Apyx Medical (APYX) for Q3 2023, worth a combined $58.7M — down 38% from $94.4M a quarter earlier.
Buyers outnumbered sellers: 18 funds opened new APYX positions and 11 closed out — a net gain of 7 holders — while 18 added to existing stakes and 10 trimmed.
The largest buyer was AIGH Capital Management, adding an estimated $2.93M. The largest seller was Divisadero Street Capital Management, cutting an estimated $10.6M.
- 62 institutional investors held Apyx Medical (APYX) as of Q3 2023, up from 56 in Q2 2023.
- Funds reported $58.7M of Apyx Medical stock for Q3 2023, down 38% quarter-over-quarter.
- 18 funds opened new Apyx Medical positions in Q3 2023 and 11 closed out, a net change of +7 holders.
- The largest Apyx Medical buyer in Q3 2023 was AIGH Capital Management, an estimated $2.93M added.
- The largest Apyx Medical seller in Q3 2023 was Divisadero Street Capital Management, an estimated $10.6M sold.
Based on aggregated 13F filings for Q3 2023.